193 related articles for article (PubMed ID: 22289504)
1. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.
Harris JA; Jain S; Ren Q; Zarineh A; Liu C; Ibrahim S
Diagn Pathol; 2012 Jan; 7():12. PubMed ID: 22289504
[TBL] [Abstract][Full Text] [Related]
2. Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma.
Mavili HS; Isisag A; Tan A; Miskioglu M; Baraz LS; Nese N
Turk Patoloji Derg; 2021; 37(2):130-138. PubMed ID: 33085074
[TBL] [Abstract][Full Text] [Related]
3. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
Abd Allah MYY; Fahmi MW; El-Ashwah S
J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Kamper P; Bendix K; Hamilton-Dutoit S; Honoré B; Nyengaard JR; d'Amore F
Haematologica; 2011 Feb; 96(2):269-76. PubMed ID: 21071500
[TBL] [Abstract][Full Text] [Related]
5. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
Azambuja D; Natkunam Y; Biasoli I; Lossos IS; Anderson MW; Morais JC; Spector N
Ann Oncol; 2012 Mar; 23(3):736-742. PubMed ID: 21602260
[TBL] [Abstract][Full Text] [Related]
6. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.
Klein JL; Nguyen TT; Bien-Willner GA; Chen L; Foyil KV; Bartlett NL; Duncavage EJ; Hassan A; Frater JL; Kreisel F
Am J Clin Pathol; 2014 Mar; 141(3):381-7. PubMed ID: 24515766
[TBL] [Abstract][Full Text] [Related]
7. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
[TBL] [Abstract][Full Text] [Related]
8. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages promote tumor cell proliferation in nasopharyngeal NK/T-cell lymphoma.
Liu Y; Fan L; Wang Y; Li P; Zhu J; Wang L; Zhang W; Zhang Y; Huang G
Int J Clin Exp Pathol; 2014; 7(9):5429-35. PubMed ID: 25337185
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Tumor Associated Macrophage Markers CD163 and CD68 Immunohistochemistry in Classical Hodgkin Lymphoma.
Rashed RA; Zaki MAM; Mohamed NAW; Mansou OM; Refaey FAHE
Clin Lab; 2021 May; 67(5):. PubMed ID: 33978358
[TBL] [Abstract][Full Text] [Related]
11. Antibody combinations for optimized staining of macrophages in human lung tumours.
Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
[TBL] [Abstract][Full Text] [Related]
12. CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.
Koh YW; Park CS; Yoon DH; Suh C; Huh J
PLoS One; 2014; 9(1):e87066. PubMed ID: 24489836
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial.
Tan KL; Scott DW; Hong F; Kahl BS; Fisher RI; Bartlett NL; Advani RH; Buckstein R; Rimsza LM; Connors JM; Steidl C; Gordon LI; Horning SJ; Gascoyne RD
Blood; 2012 Oct; 120(16):3280-7. PubMed ID: 22948049
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.
Guo B; Cen H; Tan X; Ke Q
BMC Med; 2016 Oct; 14(1):159. PubMed ID: 27745550
[TBL] [Abstract][Full Text] [Related]
15. CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma.
Yoon DH; Koh YW; Kang HJ; Kim S; Park CS; Lee SW; Suh C; Huh J
Eur J Haematol; 2012 Apr; 88(4):292-305. PubMed ID: 22044760
[TBL] [Abstract][Full Text] [Related]
16. Difference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumors.
Omatsu M; Kunimura T; Mikogami T; Shiokawa A; Nagai T; Masunaga A; Kitami A; Suzuki T; Kadokura M
Diagn Pathol; 2014 Dec; 9():215. PubMed ID: 25499804
[TBL] [Abstract][Full Text] [Related]
17. The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma.
Jakovic LR; Mihaljevic BS; Perunicic Jovanovic MD; Bogdanovic AD; Andjelic BM; Bumbasirevic VZ
Leuk Lymphoma; 2011 Oct; 52(10):1913-9. PubMed ID: 21663512
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
Steidl C; Lee T; Shah SP; Farinha P; Han G; Nayar T; Delaney A; Jones SJ; Iqbal J; Weisenburger DD; Bast MA; Rosenwald A; Muller-Hermelink HK; Rimsza LM; Campo E; Delabie J; Braziel RM; Cook JR; Tubbs RR; Jaffe ES; Lenz G; Connors JM; Staudt LM; Chan WC; Gascoyne RD
N Engl J Med; 2010 Mar; 362(10):875-85. PubMed ID: 20220182
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma.
Zaki MA; Wada N; Ikeda J; Shibayama H; Hashimoto K; Yamagami T; Tatsumi Y; Tsukaguchi M; Take H; Tsudo M; Morii E; Aozasa K
Virchows Arch; 2011 Oct; 459(4):361-6. PubMed ID: 21874508
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas.
Menter T; Bodmer-Haecki A; Dirnhofer S; Tzankov A
Hum Pathol; 2016 Aug; 54():17-24. PubMed ID: 27045512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]